A research team today announced the launch of a European large-scale clinical trial of Nilvadipine, an Alzheimer’s disease drug developed at the Roskamp Institute in Sarasota.
View post:
Key Clinical Trial of Alzheimer’s Disease Drug Begins in Europe
MONDAY, Oct. 10 (HealthDay News) — An experimental Alzheimer’s disease drug, gantenerumab, may help lower levels of amyloid plaque in the brains of people with the disease, an early clinical trial indicates.
Read the original post:
New Alzheimer’s Drug Shows Early Promise
A promising Alzheimer’s disease drug Pfizer Inc. and a partner are developing failed to work in a late-stage study, a startling disappointment after the potential blockbuster kept symptoms from worsening for a year in a prior test.
A promising Alzheimer’s disease drug Pfizer Inc. and a partner are developing failed to work in a late-stage study, a startling disappointment after the potential blockbuster kept symptoms from worsening for a year in a prior test.
Originally posted here:
... continue reading